List of Exhibits
Exhibit 1 Segmentation of Global HPV Testing Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Symptoms of HPV
Exhibit 4 Different Types of Human Papillomavirus Based on Risk
Exhibit 5 Symptoms of Advanced Cervical Cancer
Exhibit 6 Major Market Dynamics in Global HPV Testing Market
Exhibit 7 Global HPV Testing Market by Geography 2019 (%)
Exhibit 8 Global HPV Testing Market by Product 2019 (%)
Exhibit 9 Impact of Increasing Prevalence of Human Papillomavirus Infections
Exhibit 10 Cervical Cancer Incidence & Mortality Rate
Exhibit 11 Worldwide Prevalence of Human Papillomavirus Types
Exhibit 12 Impact of Growing Awareness & Favorable Guidelines Endorsing Human Papillomavirus Testing
Exhibit 13 Updated Screening Guidelines for Cervical Cancer by US Preventive Services Task Force for Women in the Age Range of 30-65 Years in August 2018
Exhibit 14 Impact of High Demand for Nucleic Acid Amplification Tests
Exhibit 15 Scenarios where HPV DNA Test is Recommended
Exhibit 16 Impact of Availability of Alternative Diagnostic Methods for Human Papillomavirus
Exhibit 17 Key Advantages of Pap Tests
Exhibit 18 Key Advantages of VIA
Exhibit 19 Impact of Increasing Focus on Preventive Measures for Human Papillomavirus Infections
Exhibit 20 Impact of HPV Vaccination on HPV Infections in Various Age Groups
Exhibit 21 Impact of Lower than Expected Market Penetration of Human Papillomavirus Tests
Exhibit 22 Key Factors Hindering the Expected Market Penetration of HPV Testing in Developing Countries
Exhibit 23 Impact of Emergence of Point-of-care/Rapid Human Papillomavirus Tests
Exhibit 24 Impact of High Growth Potential for Human Papillomavirus Tests in Low Resource Settings of LMICs
Exhibit 25 Top 10 Countries with Highest Cervical Cancer Rate in 2018
Exhibit 26 Comparison of Cervical Cancer Mortality Rates in Less Developed and Developed Countries by Age Groups
Exhibit 27 Impact of Emergence of mRNA Test for Cervical Cancer Screening
Exhibit 28 The Most Important Advantages of mRNA Human Papillomavirus Test
Exhibit 29 Impact of Increasing Demand for HPV Co-testing
Exhibit 30 Use of Human Papillomavirus DNA Testing as an Adjunct to Cytology for Cervical Cancer Screening in Women 30 Years and Older
Exhibit 31 Global HPV Testing Market 2019−2025 ($ million)
Exhibit 32 Global HPV Testing Market by Geography
Exhibit 33 Global HPV Testing Market by Product
Exhibit 34 Global HPV Testing Market by Application
Exhibit 35 Global HPV Testing Market by End-users
Exhibit 36 Five Force Analysis 2019
Exhibit 37 Incremental Growth by Product 2019-2025
Exhibit 38 Global Market by Product
Exhibit 39 Global Market Lifecycle by Product
Exhibit 40 Global Market by Product: Incremental Growth
Exhibit 41 Global Market by Product: Absolute Growth
Exhibit 42 Global Market by Product 2019−2025 ($ million)
Exhibit 43 Global Market by Product 2019−2025 (%)
Exhibit 44 Global Market by Consumables: Absolute & Incremental Growth
Exhibit 45 High-risk HPV-induced Cancers
Exhibit 46 Human Papillomavirus Testing Equipment Market 2019−2025 ($ million)
Exhibit 47 Global HPV Testing Market by Instruments: Absolute & Incremental Growth
Exhibit 48 Human Papillomavirus Testing Instruments Market 2019−2025 ($ million)
Exhibit 49 Incremental Growth by Application 2019-2025
Exhibit 50 Global Market by Application
Exhibit 51 Global Market Lifecycle by Application
Exhibit 52 Global Market by Application: Incremental Growth
Exhibit 53 Global Market by Application: Absolute Growth
Exhibit 54 Countries with Highest Cervical Cancer Rate in 2018
Exhibit 55 Potential Uses of HPV Testing
Exhibit 56 Human Papillomavirus Testing Market by Cervical Cancer: Absolute & Incremental Growth
Exhibit 57 Global Market by Cervical Cancer 2019−2025 ($ million)
Exhibit 58 Global Vaginal Cancer Incidence 2018
Exhibit 59 Global Market by Vaginal Cancer: Absolute & Incremental Growth
Exhibit 60 HPV Genotype Distribution in Vaginal Cancer Cases (%)
Exhibit 61 Global Market by Vaginal Cancer 2019−2025 ($ million)
Exhibit 62 Global Market by Other Cancers: Absolute & Incremental Growth
Exhibit 63 Global Oropharyngeal Cancer Incidence 2018
Exhibit 64 Global Vulvar Cancer Incidence 2018
Exhibit 65 Global Anal Cancer Incidence 2018
Exhibit 66 Global Penile Cancer Incidence 2018
Exhibit 67 Global HPV Testing Market by Others 2019−2025 ($ million)
Exhibit 68 Incremental Growth by End-users 2019-2025
Exhibit 69 Global Market by End-users
Exhibit 70 Global Market Lifecycle by End-users
Exhibit 71 Global Market by End-users: Absolute Growth
Exhibit 72 Global Market by End-users: Incremental Growth
Exhibit 73 Global Market by Standard Reference Laboratories: Absolute & Incremental Growth
Exhibit 74 Key Offerings by WHO LabNet for Standard Reference Laboratories
Exhibit 75 Global Market by Standard Reference Laboratories 2019−2025 ($ million)
Exhibit 76 Global Market by Hospitals: Absolute & Incremental Growth
Exhibit 77 Global Market by Hospitals 2019−2025 ($ million)
Exhibit 78 Global Market by Physicians’ Offices and Clinics: Absolute & Incremental Growth
Exhibit 79 Global Market by Physicians’ Offices and Clinics 2019−2025 ($ million)
Exhibit 80 Incremental Growth by Geography 2019-2025
Exhibit 81 Global Market by Geography
Exhibit 82 Global Market Lifecycle by Region
Exhibit 83 Global Market by Geography 2019
Exhibit 84 Global Market by Geography: Absolute Growth
Exhibit 85 Global Market by Geography: Incremental Growth
Exhibit 86 Human Papillomavirus Testing Market in North America
Exhibit 87 North America HPV Testing Market: Absolute & Incremental Growth
Exhibit 88 Market in North America 2019−2025 ($ million)
Exhibit 89 North America: Market by Product 2019 & 2025 (%)
Exhibit 90 North America: Market by Product 2019−2025 ($ million)
Exhibit 91 North America: Market by Product 2019−2025 (%)
Exhibit 92 Incremental Growth in North America 2019−2025
Exhibit 93 Market in US 2019−2025 ($ million)
Exhibit 94 Market in Canada 2019−2025 ($ million)
Exhibit 95 Europe HPV Testing Market 2019
Exhibit 96 Europe Market: Absolute & Incremental Growth
Exhibit 97 Market in Europe 2019–2025 ($ million)
Exhibit 98 Incremental Growth in Europe 2019-2025
Exhibit 99 Europe: Market by Product 2019−2025 ($ million)
Exhibit 100 Europe: Market by Product 2019−2025 (%)
Exhibit 101 Market in UK 2019−2025 ($ million)
Exhibit 102 The YPA Program Mainly Includes
Exhibit 103 Market in France 2019–2025 ($ million)
Exhibit 104 Market in Germany 2019–2025 ($ million)
Exhibit 105 Market in Italy 2019–2025 ($ million)
Exhibit 106 Market in Spain 2019–2025 ($ million)
Exhibit 107 APAC HPV Testing Market 2019
Exhibit 108 APAC Market: Absolute & Incremental Growth
Exhibit 109 Market in APAC 2019–2025 ($ million)
Exhibit 110 APAC: Market by Product 2019−2025 ($ million)
Exhibit 111 APAC: Market by Product 2019−2025 (%)
Exhibit 112 Incremental Growth in APAC 2019-2025
Exhibit 113 Market in Japan 2019–2025 ($ million)
Exhibit 114 Market in China 2019–2025 ($ million)
Exhibit 115 Market in Australia 2019–2025 ($ million)
Exhibit 116 Market in South Korea 2019–2025 ($ million)
Exhibit 117 Market in India 2019–2025 ($ million)
Exhibit 118 Latin America HPV Testing Market 2019
Exhibit 119 Latin America Market: Absolute & Incremental Growth
Exhibit 120 Market in Latin America 2019–2025 ($ million)
Exhibit 121 Latin America: Market by Product 2019−2025 ($ million)
Exhibit 122 Latin America: Market by Product 2019−2025 (%)
Exhibit 123 Incremental Growth in Latin America 2019-2025
Exhibit 124 Market in Brazil 2019–2025 ($ million)
Exhibit 125 Market in Mexico 2019–2025 ($ million)
Exhibit 126 Market in Mexico 2019–2025 ($ million)
Exhibit 127 MEA HPV Testing Market 2019
Exhibit 128 MEA Market: Absolute & Incremental Growth
Exhibit 129 Middle East and North Africa Cervical Cancer Deaths
Exhibit 130 Market in MEA 2019–2025 ($ million)
Exhibit 131 MEA: Market by Product 2019−2025 ($ million)
Exhibit 132 MEA: Market by Product 2019−2025 (%)
Exhibit 133 Incremental Growth in MEA 2019-2025
Exhibit 134 Market in Turkey 2019–2025 ($ million)
Exhibit 135 Market in South Africa 2019–2025 ($ million)
Exhibit 136 Market in Saudi Arabia 2019–2025 ($ million)
Exhibit 137 Global HPV Testing Market Share: Vendors Share 2019
Exhibit 138 F. Hoffmann-La Roche: Revenue by Business Segments in 2017−2018 ($ billion)
Exhibit 139 F. Hoffmann-La Roche: R&D Expenditure in 2016−2018 ($ billion)
Exhibit 140 F. Hoffmann-La Roche: Revenue by Geography ($ billion)
Exhibit 141 QIAGEN: Revenue by Business Segments in 2017−2018 ($ million)
Exhibit 142 QIAGEN: R&D Expenditure in 2016−2018 ($ million)
Exhibit 143 QIAGEN: Revenue by Geography in 2018 ($ million)
Exhibit 144 Hologic: Revenue by Segments 2018−2019 ($ million)
Exhibit 145 Hologic: R&D Expenditure 2017−2019 ($ million)
Exhibit 146 Hologic: Revenue by Geography 2019 ($ million)
Exhibit 147 Abbott: Revenue by Segments 2017−2018 ($ million)
Exhibit 148 Abbott: R&D Expenditure 2016−2018 ($ million)
Exhibit 149 Abbott: Revenue by Geography ($ million)
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2014−2019
Table 3 High-risk HPV-induced Cancers
Table 4 Major Vendors Offering HPV Testing Solutions
Table 5 Market Penetration of Human Papillomavirus Test by Regions
Table 6 Commercially Available POC HPV Products
Table 7 Absolute Growth of Human Papillomavirus Testing in Developed and Emerging Economies (%)
Table 8 Commercially Available mRNA Test
Table 9 List of Key HPV Testing Instruments from Market Players
Table 10 Key HPV Diagnostic Analyzers Available in the Market
Table 11 Significant Players Offering Human Papillomavirus Testing Products for the Detection of Cervical Cancer
Table 12 Classification of Human Papillomavirus Associated Penile Carcinomas, Relative Frequency and Mean Cancer-Specific Mortality by WHO
Table 13 Healthcare Expenditure as Percent of GDP in Major Latin American Countries
Table 14 Global HPV Testing Market: Top Vendors Ranking
Table 15 F. Hoffmann-La Roche: Key Product Offerings
Table 16 QIAGEN: Key Product Offerings
Table 17 Hologic: Key Product Offerings
Table 18 Abbott: Key Product Offerings
Table 19 Arbor Vita: Key Product Offerings
Table 20 BD: Key Product Offerings
Table 21 Cepheid: Key Product Offerings
Table 22 DAAN Gene: Key Product Offerings
Table 23 DiaCarta: Key Product Offerings
Table 24 Fujirebio: Key Product Offerings
Table 25 Greiner Bio-One International: Key Product Offerings
Table 26 Hybribio: Key Product Offerings
Table 27 IncellDx: Key Product Offerings
Table 28 Norgen Biotek: Key Product Offerings
Table 29 PreTect: Key Product Offerings
Table 30 Seegene: Key Product Offerings
Table 31 Siemens Healthineers: Key Product Offerings
Table 32 Takara Bio: Key Product Offerings
Table 33 Xiamen Zeesan Biotech: Key Product Offerings
Table 34 ZYTOVISION: Key Product Offerings
Table 35 Global Human Papillomavirus Testing Market by Product ($ million)
Table 36 Market by Product (%)
Table 37 Market by Application ($ million)
Table 38 Market by Application (%)
Table 39 Market by End-users ($ million)
Table 40 Market by End-users (%)
Table 41 Market by Geography ($ million)
Table 42 Market by Geography (%)